MAPK14 and metabolic dysfunction-associated steatohepatitis: Scoparone ameliorated hepatic inflammation of mice with nonalcoholic steatohepatitis by regulating the ROS/P38/Nrf2 axis and PI3K/AKT/mTOR pathway in macrophages (42).